These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23969574)

  • 1. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialty compounding for improved patient care: a national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2006; 10(6):462-8. PubMed ID: 23974420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current Landscape of Veterinary Compounding in the Pharmacy Setting.
    Gochenauer AE; Holmes ER; Barber KE; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):422-427. PubMed ID: 31513542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent community pharmacists' perspectives on compounding in contemporary pharmacy education.
    Martin KS; McPherson TB; Fontane PE; Berry T; Chereson R; Bilger R
    Am J Pharm Educ; 2009 May; 73(3):54. PubMed ID: 19564997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacy compounding-impact on professional status.
    Giam JA; McLachlan AJ; Krass I
    Int J Clin Pharm; 2011 Apr; 33(2):177-82. PubMed ID: 21448656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Records and record-keeping for the hospital compounding pharmacist.
    McElhiney LF
    Int J Pharm Compd; 2007; 11(2):136-41. PubMed ID: 23974620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.